WASHINGTON — Kim Kardashian is no stranger to criticism, having spent the better part of the last decade in the public eye. But she's probably never faced negative publicity like this before: The Food and Drug Administration says Kardashian's social media posts violate federal drug-promotion rules.
Kardashian, who is five months pregnant with her second child with husband Kanye West, recently began promoting a prescription pill to treat morning sickness through her social media accounts.
"I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor," posts to Instagram and Facebook stated. "He prescribed me #Diclegis, and I felt a lot better and most importantly, it's been studied and there was no increased risk to the baby."
The posts link to a company website that includes the FDA-approved labeling information.
But FDA regulators say the posts violate rules for promoting drugs because they don't mention side effects of Diclegis, which include sleepiness that can make it dangerous to drive. The drug label warns that Diclegis, the only prescription drug approved in the United States for morning sickness, should not be combined with alcohol or other medications that cause drowsiness.
The FDA posted a warning letter online Tuesday, addressed to the CEO of Canadian drugmaker Duchesnay Inc., which markets the drug. The letter notes that the privately held company received a similar warning in 2013 for omitting risk information from a letter to doctors. FDA regulators are "concerned that Duchesnay is continuing to promote Diclegis in a violative manner," states the letter dated Aug. 7. The agency calls on the company to remove the social media posts immediately and outline a plan for preventing future violations by Aug. 21
Duchesnay said in a statement it "will take quick action in responding to the FDA's letter and immediately and effectively address any issues."
Kardashian's publicist did not immediately respond to a request for comment Tuesday. The posts cited no longer appeared on her accounts Tuesday afternoon.